Dexmethylphenidate

Back to search

Molecule Structure

Scientific Name

Dexmethylphenidate

Description of the Drug

Dexmethylphenidate is a norepinephrine-dopamine reuptake inhibitor used in the treatment of ADHD in conjunction with other therapies.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB06701

Brand Name(s)

Not Available

Company Owner(s)

Lannett Co Inc, Impax Laboratories Inc, Novartis Pharmaceuticals Corp, Mylan Pharmaceuticals Inc A Viatris Co, Par Pharmaceutical Inc, Uspharma Ltd, Mylan Pharmaceuticals Inc, Teva Pharmaceuticals Usa, Sun Pharmaceutical Industries Inc, Rhodes Pharmaceuticals Lp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Norepinephrine transporter SINGLE PROTEIN INHIBITOR CHEMBL222
Dopamine transporter SINGLE PROTEIN INHIBITOR CHEMBL238

Unichem Links

SureChEMBL SCHEMBL34326
Human Metabolome Database HMDB0015647
DrugBank DB06701
PubChem: Thomson Pharma 14847270 15121721
PubChem 154101
Nikkaji J343.157F
BindingDB 50062915
EPA CompTox Dashboard DTXSID70893769
DrugCentral 836
Brenda 72091 161119
Guide to Pharmacology 7554
GSRS c01838fb-a50c-4f19-a3f5-48f0dadf4908
rxnorm DEXMETHYLPHENIDATE HYDROCHLORIDE DEXMETHYLPHENIDATE FOCALIN
ChEBI 51860
ZINC ZINC000000896711